Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,43 € ↓ -0,01 (-0,01%)
2026-06-04
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionWhalerock Point Partners, Llc
Latest Disclosed Ownership5,534 shares
Latest Disclosed Value $ 335,637
Whalerock Point Partners, Llc ownership in BRM / Bristol-Myers Squibb Company

On May 15, 2026 - Whalerock Point Partners, Llc filed a 13F-HR form disclosing ownership of 5,534 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $290,092 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 5,534 shares of Bristol-Myers Squibb Company. This represents a change in shares of 0.00% during the quarter. The current value of the position is $262,478 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F Bristol-Myers Squibb COM 110122108 5,534 0 0.00 336 12.42 0.0648
2026-02-13 2025-12-31 13F Bristol-Myers Squibb COM 110122108 5,534 -312 -5.34 299 13.31 0.0568
2025-11-12 2025-09-30 13F Bristol-Myers Squibb COM 110122108 5,846 -100 -1.68 264 -4.36 0.0535
2025-08-13 2025-06-30 13F Bristol-Myers Squibb COM 110122108 5,946 0 0.00 275 -24.03 0.0595
2025-05-15 2025-03-31 13F Bristol-Myers Squibb COM 110122108 5,946 -200 -3.25 363 4.32 0.0861
2025-02-14 2024-12-31 13F Bristol-Myers Squibb COM 110122108 6,146 -236 -3.70 348 5.15 0.0808
2024-11-13 2024-09-30 13F Bristol-Myers Squibb COM 110122108 6,382 -150 -2.30 330 21.77 0.0786
2024-08-13 2024-06-30 13F Bristol-Myers Squibb COM 110122108 6,532 -5,300 -44.79 271 -57.72 0.0726
2024-05-15 2024-03-31 13F Bristol-Myers Squibb COM 110122108 11,832 -144 -1.20 642 4.40 0.1750
2024-02-14 2023-12-31 13F/A-1 Bristol-Myers Squibb COM 110122108 11,976 -2,171 -15.35 614 -25.21 0.1900
2024-02-14 2023-12-31 13F Bristol-Myers Squibb COM 110122108 11,976 -2,171 614 0.1900
2023-11-14 2023-09-30 13F Bristol-Myers Squibb COM 110122108 14,147 0 0.00 821 -9.18 0.2844
2023-08-14 2023-06-30 13F Bristol-Myers Squibb COM 110122108 14,147 251 1.81 905 -6.13 0.3069
2023-05-10 2023-03-31 13F Bristol-Myers Squibb COM 110122108 13,896 0 0.00 963 -3.60 0.3580
2023-02-14 2022-12-31 13F Bristol-Myers Squibb COM 110122108 13,896 -14 -0.10 1,000 0.4064
2022-11-16 2022-09-30 13F/A-1 Bristol-Myers Squibb COM 110122108 13,910 0 0.00 1 -100.00 0.4346
2022-11-15 2022-09-30 13F Bristol-Myers Squibb COM 110122108 989 -12,921 989 0.4260
2022-08-12 2022-06-30 13F Bristol-Myers Squibb COM 110122108 13,910 0 0.00 1 -99.90 0.4527
2022-05-16 2022-03-31 13F Bristol-Myers Squibb COM 110122108 13,910 -447 -3.11 1,016 13.41 0.3599
2022-02-15 2021-12-31 13F Bristol-Myers Squibb COM 110122108 14,357 -987 -6.43 895 0.3067
2021-11-12 2021-09-30 13F Bristol-Myers Squibb COM 110122108 15,344 -73 -0.47 1 -100.00 0.3518
2021-08-10 2021-06-30 13F Bristol-Myers Squibb COM 110122108 15,417 -100 -0.64 1,030 5.21 0.3960
2021-05-13 2021-03-31 13F Bristol-Myers Squibb COM 110122108 15,517 0 0.00 980 1.66 0.4308
2021-02-12 2020-12-31 13F Bristol-Myers Squibb COM 110122108 15,517 14,593 1,579.33 963 4.22 0.4570
2020-11-13 2020-09-30 13F Bristol-Myers Squibb COM 110122108 924 -16,785 -94.78 924 -11.24 0.5098
2020-08-11 2020-06-30 13F Bristol-Myers Squibb COM 110122108 17,709 -13,755 -43.72 1,041 -40.65 0.6141
2020-05-15 2020-03-31 13F Bristol-Myers Squibb COM 110122108 31,464 -500 -1.56 1,754 -14.52 1.2549
2020-02-12 2019-12-31 13F Bristol-Myers Squibb COM 110122108 31,964 857 2.76 2,052 30.12 1.0910
2019-11-12 2019-09-30 13F Bristol-Myers Squibb COM 110122108 31,107 0 0.00 1,577 11.76 0.8501
2019-08-09 2019-06-30 13F Bristol-Myers Squibb COM 110122108 31,107 0 0.00 1,411 -4.92 0.8060
2019-05-13 2019-03-31 13F Bristol-Myers Squibb COM 110122108 31,107 600 1.97 1,484 -6.43 0.9704
2019-03-04 2018-12-31 13F Bristol-Myers Squibb COM 110122108 30,507 0 0.00 1,586 -16.26 1.4757
2019-03-04 2018-09-30 13F Bristol-Myers Squibb COM 110122108 30,507 0 0.00 1,894 12.20 1.3747
2019-03-04 2018-06-30 13F Bristol-Myers Squibb COM 110122108 30,507 -1,950 -6.01 1,688 -17.74 1.3482
2018-04-05 2018-03-31 13F Bristol-Myers Squibb COM 110122108 32,457 0 0.00 2,052 3.17 0.6574
2018-01-16 2017-12-31 13F Bristol-Myers Squibb COM 110122108 32,457 -1,142 -3.40 1,989 -7.14 0.6297
2017-10-31 2017-09-30 13F Bristol-Myers Squibb COM 110122108 33,599 0 0.00 2,142 14.42 0.7562
2017-08-08 2017-06-30 13F Bristol-Myers Squibb COM 110122108 33,599 -2,942 -8.05 1,872 -5.79 0.6872
2017-04-19 2017-03-31 13F Bristol-Myers Squibb COM 110122108 36,541 4,884 15.43 1,987 7.41 0.7419
2017-03-01 2016-12-31 13F Bristol-Myers Squibb COM 110122108 31,657 185 0.59 1,850 9.08 0.7281
2016-11-18 2016-09-30 13F BRISTOL MYERS SQUIBB COM 110122108 31,472 150 0.48 1,696 -15.20 0.7018
2016-05-25 2016-03-31 13F BRISTOL MYERS SQUIBB COM 110122108 31,322 -700 -2.19 2,000 -9.17 0.8628
2016-02-10 2015-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 32,022 -2,630 -7.59 2,202 7.36 0.9584
2015-11-09 2015-09-30 13F BRISTOL MYERS SQUIBB COM 110122108 34,652 -142 -0.41 2,051 -11.40 0.8845
2015-07-28 2015-06-30 13F BRISTOL MYERS SQUIBB COM 110122108 34,794 0 0.00 2,315 3.16 0.9568
2015-06-09 2015-03-31 13F BRISTOL MYERS SQUIBB COM 110122108 34,794 0 0.00 2,244 9.30 0.9143
2015-02-24 2014-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 34,794 -111 -0.32 2,053 14.95 0.8671
2014-11-17 2014-09-30 13F BRISTOL MYERS SQUIBB COM 110122108 34,905 0 0.00 1,786 5.49 0.8059
2014-08-26 2014-06-30 13F BRISTOL MYERS SQUIBB COM 110122108 34,905 465 1.35 1,693 -5.37 0.8044
2014-05-29 2014-03-31 13F BRISTOL MYERS SQUIBB COM 110122108 34,440 0 0.00 1,789 -2.24 0.9115
2014-02-18 2013-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 34,440 34,440 1,830 0.9567
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.